•
Mar 31, 2017

Vaxart Q3 2017 Earnings Report

Total Revenue
$2.31M
Previous year: $5.4M
-57.2%
EPS
-$25.8
Previous year: -$0.14
+18357.1%
Gross Profit
$2.31M
Previous year: $5.3M
-56.4%
Cash and Equivalents
$3.29M
Previous year: $30.6M
-89.3%
Free Cash Flow
-$4.36M
Previous year: -$7.1M
-38.7%
Total Assets
$46.7M
Previous year: $61.9M
-24.6%

Vaxart

Vaxart